lung ca

Lung Cancer Overview

  • Lung cancer is primarily caused by exposure to tobacco smoke.
    • Tobacco Smoke: The number one cause of lung cancer.
    • Genetic Factors: Contribute to the likelihood of developing lung cancer.
    • Occupational Contributions: Limited number of occupational exposures are known to contribute to lung cancer.

Occupational Exposures Related to Lung Cancer

  • Asbestos:

    • Associated with lung cancer and mesothelioma.
    • Mortality Rate: 14% five-year survival rate.
    • Up to 20-25% of deaths among heavily exposed workers result from oncogenic carcinoma.
    • Estimated that 4-12% of lung cancers can be attributed to asbestos exposure.
    • Latency period from exposure to lung cancer diagnosis: 15-30 years.
  • Other Chemicals:

    • Occupational exposure to:
    • Arsenic
    • Beryllium
    • Chromium
  • Environmental Exposures:

    • Radon: Significant community exposure potentially becomes the second leading cause of lung cancer in the US after tobacco smoking.

Evidence of Asbestos and Lung Cancer Relationship

  • Causal Relationship: Established in the mid-1950s primarily through research on shipyard workers at centers like Mount Sinai, New York.

    • Studies point to a dose-response relationship:
    • Higher levels of asbestos exposure correlate with increased risk of lung cancer.
    • Example Risk Ratios:
    • Shipyard workers (1940s): 1.7 times higher risk.
    • Insulation workers (1960s-1970s): Up to 5 times higher risk than the general population.
  • Combination of Asbestos and Tobacco Exposure:

    • Relative risk of lung cancer from asbestos exposure:
    • Estimated between 1.7 and 5 times that of unexposed individuals.
    • Relative risk of lung cancer for tobacco smokers:
    • Estimated at 11-25 times greater than non-smokers.
    • Combining smoking and asbestos exposure can increase the relative risk significantly (50-100 times).
  • Preventive Measures:

    • Critical counseling for exposed workers to cease smoking due to high-risk combination.

Assessing Causality of Asbestos Exposure in Lung Cancer Patients

  • Helsinki Criteria (1997): Developed to assess whether lung cancer resulted from asbestos exposure.

    • Pathological evidence (presence of asbestos in lung tissue) serves as a marker for exposure.
    • Cumulative exposure criteria:
    • Minimum 25 fiber years considered.
    • At least one year of heavy exposure or five to ten years of moderate exposure.
    • Requires a lag time of at least 10 years post-exposure before disease onset.
  • Imaging and Diagnosis:

    • CT scans may show solitary pulmonary nodules or masses that indicate lung cancer.

Mesothelioma

  • Definition:

    • Tumor that arises from the linings of the pleura (lungs) or peritoneal cavity.
  • Epidemiology:

    • Rare disease: 15 cases per million in males; 3 cases per million in females.
    • Symptoms often present at advanced stages, typically with chest pain and pleural effusions.
    • Latency period: Usually 30-40 years, which can be as short as 10 years in some cases.
  • Prognosis and Survival Rates:

    • Poor prognosis with a one-year survival rate of less than 30
      t.
    • Average survival following diagnosis ranges between 8-14 months.
  • Pathophysiology:

    • Mechanisms are not fully understood; involves release of cytokines causing fibrosis and inflammation following asbestos exposure.
    • Amphibole fibers are more pathogenic compared to serpentine fibers, although Chrysotile fibers also show some association with mesothelioma.
  • Asbestosis Relationship:

    • There is a predominance of patients with asbestosis developing mesothelioma.
    • Even without clear evidence of asbestos in tissue, upwards of 10% of patients may still develop mesothelioma.
  • Epidemiological Trends:

    • Rates haven’t significantly changed over the past decades, remaining relatively stable.
    • Lack of substantial decline in mortality, despite awareness of asbestos hazards in building materials.
  • Imaging Evidence:

    • CT images may reveal extensive tumors relating to mesothelioma.

Next Steps

  • Discussion on medical screening for asbestosis and its implications for lung cancer risk assessment.